Lipocine Net Receivables from 2010 to 2025

LPCN Stock  USD 3.68  0.14  3.95%   
Lipocine Net Receivables yearly trend continues to be very stable with very little volatility. Net Receivables is likely to drop to about 44.7 K. During the period from 2010 to 2025, Lipocine Net Receivables quarterly data regression pattern had sample variance of 667.7 B and median of  144,536. View All Fundamentals
 
Net Receivables  
First Reported
2015-06-30
Previous Quarter
91.5 K
Current Value
120.4 K
Quarterly Volatility
767.9 K
 
Yuan Drop
 
Covid
Check Lipocine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lipocine's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 5.8 M or Total Revenue of 11.8 M, as well as many indicators such as Price To Sales Ratio of 2.21, Dividend Yield of 0.0 or PTB Ratio of 1.3. Lipocine financial statements analysis is a perfect complement when working with Lipocine Valuation or Volatility modules.
  
Check out the analysis of Lipocine Correlation against competitors.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.

Latest Lipocine's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Lipocine over the last few years. It is Lipocine's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lipocine's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Very volatile
   Net Receivables   
       Timeline  

Lipocine Net Receivables Regression Statistics

Arithmetic Mean334,728
Geometric Mean83,218
Coefficient Of Variation244.11
Mean Deviation416,674
Median144,536
Standard Deviation817,110
Sample Variance667.7B
Range3.3M
R-Value(0.02)
Mean Square Error715B
R-Squared0.0005
Significance0.94
Slope(3,700)
Total Sum of Squares10T

Lipocine Net Receivables History

202544.7 K
202447 K
202352.3 K
2022659.9 K
2021247.3 K
2020 391.0
201916.5 K

About Lipocine Financial Statements

Lipocine investors utilize fundamental indicators, such as Net Receivables, to predict how Lipocine Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables47 K44.7 K
When determining whether Lipocine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lipocine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lipocine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lipocine Stock:
Check out the analysis of Lipocine Correlation against competitors.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
2.097
Quarterly Revenue Growth
15.15
Return On Assets
(0.03)
Return On Equity
0.0004
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.